Aims: MicroRNAs (miRNAs) are dysregulated in a wide range of malignant diseases, confirming their crucial role in tumor metastasis. MiRNA-30a-5p, a member of the miR-30 family, has been implicated in many types of cancers, including colorectal cancer, a leading cause of death worldwide. Methods: qRT-PCR, Western blot, Transwell assay,luciferase reporter assay were performed in the present study. Results: In this study, miR-30a-5p was found to be significantly downregulated in human colorectal cancer tissue specimens and cell lines compared with non-cancerous tissues and cells. The overexpression of miR-30a-5p inhibited the migratory and invasive abilities of colorectal cancer cells and suppressed the epithelial-mesenchymal transition, a crucial process in metastasis. Bioinformatic algorithms and luciferase reporter assays revealed that integrin β3 (ITGB3) is a direct target of miR-30a-5p. Importantly, overexpression of ITGB3 in colorectal cancer cells rescued these cells from miR-30a-5p-mediated suppression of metastasis and restored the epithelial-mesenchymal transition. Conclusion: Taken together, our study provides the first evidence that miR-30a-5p suppresses colon cancer metastasis through the inhibition of ITGB3. Thus, targeting miR-30a-5p might serve as a promising therapeutic strategy for the treatment of colorectal cancer.
MiR-30a-5p Suppresses Tumor Metastasis of Human Colorectal Cancer by Targeting ITGB3

Introduction
MiRNAs are evolutionarily conserved, endogenous, non-coding small RNAs (18-25 nucleotides in length) that negatively regulate gene expression by binding to specific target mRNAs, leading to either cleavage or translational inhibition [1] . It is now believed that each miRNA is capable of modulating the expression of hundreds of target genes, thereby affecting a diverse range of biological processes [2] . Over the last decade, miRNAs have been recognized as critical regulators in the development and progression of cancer via the modulation of cellular pathways, such as those involved in proliferation [3] , differentiation [4, 5] , apoptosis [6, 7] and invasion [8] [9] [10] . In a number of human cancers, including colon, breast, lung and stomach cancer, as well as leukemia and lymphoma, miRNA expression profiles have been reported to differ significantly between carcinoma cells and corresponding non-carcinoma cells [3, 4, 11] . The dysregulation of miRNA expression in a wide range of malignant diseases has confirmed the crucial role of miRNAs in tumor metastasis [12] , however, in many cases it remains to be determined which step(s) in the multistep metastatic process these miRNAs regulate.
In the case of colorectal cancer (CRC), one of the leading causes of death worldwide [13] , global miRNA expression analyses have identified multiple dysregulated miRNAs including miRNA-21 [14] , miRNA-124 [15] , miRNA-625 [16] , miRNA-339-5p [17] , miRNA-27b [18] , although their functional roles are yet to be confirmed experimentally in the majority of cases. It was confirmed that a series of miRNAs, including miR-140-5p [19] , miR-149 [20] , miR-301α [21] , play importat roles in the development of colorectal cancer. In addition, miRNA 30a(miR-30a-5p), a member of the miR-30 family, has been repeatedly reported to be downregulated in a number of cancers including CRC [22] [23] [24] . Studies have shown that miRNA-30a can act as a tumor suppressor, inducing growth inhibition and suppression of cell migration and invasion in CRC, by targeting denticleless protein homolog, PIK3CD and insulin receptor substrate 2 [25] [26] [27] . miRNAs have also been reported to modulate the expression of integrins, transmembrane receptors involved in signal transduction, and dysfunction in miRNA-regulated integrin signaling has been linked to tumor metastasis and apoptosis in a number of cancers including CRC [28] .
The conversion of an epithelial cell to a mesenchymal cell, known as epithelialmesenchymal transition (EMT) is critical to embryonic morphogenesis. It is also now wellestablished that EMT plays a specific role in the migration of cells from a primary tumor into the circulation, the process of metastasis, which is often a crucial prognostic factor [29] [30] [31] . The loss of epithelial functions and the acquisition of mesenchymal functions during EMT is accompanied by increased migratory and invasive properties. TGF-β and RTK/Ras signaling, autocrine factors and Wnt-, Notch-, Hedgehog-and NF-κB-dependent pathways have been reported to contribute to EMT. Repression of E-cadherin by transcriptional regulators such as Snai1 or Twist is known to be a critical step driving EMT [32] . In fact, reduced E-cadherin protein expression (an epithelial-specific marker) is used as an indicator of EMT, as is increased expression of vimentin (a mesenchymal-specific marker) [33] . A recent report by Liu et al. [10] identified Snai1 as a direct target of miRNA-30a and demonstrated miRNA-30a as a novel regulator of EMT. Similarly, another study reported that miRNA-29b suppresses CRC metastasis by regulating EMT via its target Tiam1 [34] .
Here, we investigated further the role of miRNA-30a-5p in CRC progression and the mechanisms underlying the function of miR-30a-5p in CRC metastasis. We identified ITGB3 as a direct target of miR-30a-5p and revealed the relationship between miR-30a-5p, ITGB3 and the EMT. 
Materials and Methods
Clinical specimens
Lentiviral production and infection oligonucleotide transfection
The miR-30a-5p precursor sequence was amplified with the following primers: 5´-TAC GGA TCC CCT TCA TCT TAC TTT TTT CCC CCA A-3´ (forward) and 5´-ATC GCT AGC GAA ACT AGAAGCTCGGTGATGAATA-3´ (reverse). These sequences were cloned into the lentivirusbased expression plasmid pLenti6.3 (Invitrogen). Virus packaging and infection were performed according to standard protocols as recommended by the manufacturer. Lovo and SW480 cells (1x10 5 ) were infected with 1x10 7 lentivirus transducing units in the presence of 10 μg/ml polybrene (Sigma, St Louis, Missouri, USA). Empty lentiviral vector was used as negative control. Cells were collected 48 h after transfection.
qRT-PCR analysis
Total RNA was extracted with Trizol reagents (Life Technologies, CA, USA) according to the manufacturer's instructions. Then, 1 μg of RNA was reverse transcribed into cDNA using a reverse reaction kit (Promega, Madison, WI, USA). qRT-PCR was then performed using specific primers and the 7500 real-time PCR system (Applied Biosystems, Mannheim, Germany). U6 was used as the endogenous control for miRNA expression analysis. Relative quantification analysis was performed using the comparative threshold cycle (CT) method (2-ΔΔCT) [36] .
Transwell assay
Migration and invasion of LoVo and SW480 cells were assessed using Transwell plates (Millipore). Cells were plated on uncoated upper chambers (24-well inserts; pore size, 8 mm; BD Bioscience, Bedford, MA, USA) for Transwell migration assays. Cells were plated on Matrigel-coated upper chambers (24-well inserts; pore size, 8 mm; BD Bioscience) for invasion assays. Briefly, fresh media containing 5% fetal bovine serum (FBS) were placed in the lower wells. Cells were incubated for 24 h in medium containing 1% FBS, trypsinized, and suspended at a final concentration of 1×10 6 cells/mL in medium containing 1% FBS. Then, 200 mL of the cell suspension was loaded into each of the upper wells, and the chamber was incubated at 37°C for 24 h. Non-migrating cells on the upper surface of the filter were removed by wiping with a cotton swab. Chemotaxis was quantified by counting the cells that migrated to the lower side of the filter for eight random fields in each assay with an optical inverted microscope (×200, Nikon, Tokyo, Japan).
Western blot analysis
Equal amounts of cell lysate were separated by 10% SDS-PAGE, and electrophoretically transferred to PVDF membrane. The membrane was blocked and probed with mouse antihumanITGB3 monoclonal antibody (Abcam, Cambridge, UK), followed by horseradish peroxidase-labeled goat-anti-mouse IgG (Abcam). Chemiluminescence was used to analyze protein levels and β-actin was used as a protein loading control.
Bioinformatic analysis
Potential miRNA targets were predicted and analyzed using three publicly available algorithms: PicTar, TargetScan and miRanda [37] . The number of false-positive results was decreased by accepting only putative target genes that were predicted by at least two programs. Luciferase reporter assay HEK293T cells were seeded in a 96-well plate at 50-60% confluence. After 24 h, cells were transfected with 120 ng of miRNA-30a-5p expression vector, miRNA-30a-5p inhibitor, control vector, or negative control. Cells were co-transfected with 30 ng of the wild-type or mutant 3ʹ-UTR of ITGB3 mRNA. Transfections were performed using 0.45 μL of Fugene (Promega, Madison, WI, USA). Cells were collected 48 h after transfection, and Renilla luciferase activity was measured using a dual-luciferase reporter system (Promega). Luciferase reporter assays were performed in duplicate and repeated in three independent experiments. Luciferase activity was detected using an Orion II microplate luminometer (Berthold Technologies, Germany).
Liver metastasis model
Mice were injected with SW480 colon cancer cells in the spleen to produce liver metastasis. The mice were anesthetized with 2.5% pentobarbital sodium by peritoneal injection. After sterilization of the skin in the area of surgery, an abdominal incision paralleling the left subcostal margin was made. Tumor cells (1×10
7
) in 100 μl phosphatebuffered saline solution were injected into the spleen. Mice were euthanized 5 weeks after tumor cell implantation. Liver metastases were examined and counted under a dissecting microscope equipped with bright field imaging.
Statistical analysis
Statistical analysis was performed using SPSS 15.0 software (SPSS Inc., Chicago, IL, USA). Data are expressed as the mean ± SEM. The difference between two independent groups was assessed using a two-tail Student's t test. A p value <0.05 was considered statistically significant. All experiments were performed in triplicate.
Results
MiR-30a-5p is downregulated in CRC tissue and cell lines
We compared miR-30a-5p expression in 40 CRC tissues with metastases (mCRC) and 27 CRC tissues without metastases (nmCRC) and 40 normal non-cancerous matched tissues (Normal) by qRT-PCR. The average relative expression level of miR-30a-5p was significantly lower in CRC specimens compared with non-cancerous tissues (Fig. 1A, P<0 .01). Decreased expression of miR-30a-5p was also observed in all four CRC cell lines tested (HT29, LoVo, SW116 and SW480) compared with the normal human colon epithelial cell line NCM460 or Fig. 3A and B ). E-cadherin and vimentin are markers of EMT. Reduced expression of the epithelial-specific marker E-cadherin, accompanied by increased expression of the mesenchymal-specific marker vimentin, is indicative of EMT (Zeisberg and Neilson, 2009). Our findings therefore indicate that exogenous miR-30a-5p inhibits EMT in CRC cells, which is consistent with the suppression of invasive and migratory properties in these cells shown in Fig. 2 .
ITGB3 is a target for repression by miR-30a-5p
MiRNAs act by binding to the 3ʹUTR of target genes sharing sequence homology within the seed sequence. To explore miR-30a-5p-regulated target gene(s) and pathway(s), we used three publicly-available miRNA target prediction tools: Targetscan, ncRNA and mirecords. To increase the stringency of the target prediction protocol, we searched for mRNAs simultaneously predicted by all three target-prediction programs and selected ITGB3 as a potential target. To assess whether miR-30a-5p could directly alter the expression of ITGB3, a putative binding site for miR-30a-5p in the 3'UTR of ITGB3 was identified (Fig. 4A ) and this mRNA fragment (wt 3ʹUTR), along with a mutated derivative of this sequence (mut 3ʹUTR), were cloned into a luciferase reporter vector. HEK-293T cells were then transfected with the reporter vectors containing either the wt or mut 3ʹUTR of ITGB3 and a miR-30a-5p mimic. As shown in Fig. 4B , luciferase expression was decreased when the wt 3ʹUTR and miR-30a-5p mimic were cotransfected (P<0.01), while cotransfection with the mut 3ʹUTR had no effect on luciferase activity. Moreover, cotransfection of HEK-293T cells with the wt 3ʹUTR and anti-miR-30a-5p reversed the effect seen with the miR-30a-5p mimic (P<0.01).
Collectively, these results indicated that ITGB3 is a direct target of miR-30a-5p. We next elucidated whether the growth-suppressive effect of miR-30a-5p was mediated by repression of ITGB3. We assessed whether expression of ITGB3 changed in response to transfection with the miR-30a-5p mimic or anti-miR-30a-5p in SW480 cells by western blot analysis. Compared with the nonspecific controls, expression of ITGB3 was significantly decreased by miR-30a-5p transfection and increased by anti-miR-30a-5p transfection (Fig. 4C) , indicating that miR-30a-5p decreases ITGB3 expression.
ITGB3 rescues the suppressive effect of miR-30a-5p on CRC cell metastasis
To identify whether miR-30a-5p inhibits the invasiveness of CRC cells by targeting ITGB3, we performed a "rescue" experiment by co-transfecting SW480 CRC cells with miR-30a-5p mimics and a pcDNA3.1 vector that expresses ITGB3 with a mutated miR-30a seed sequence 
ITGB3 rescues the suppressive effect of miR-30a-5p on EMT
Finally, we investigated the effect of ITGB3 on EMT. Western blot analysis of ITGB3, vimentin and E-cadherin expression in cells co-transfected with miR-30a-5p mimics and pcDNA3.1-ITGB3 harboring the wild-type or mutant miR-30a-5p response element, revealed that ITGB3 restored the expression of vimentin and inhibited the expression of E-cadherin (Fig. 6) , thereby rescuing the suppressive effect of miR-30a-5p on EMT. 6 . ITGB3 restores the expression of vimentin and inhibits the expression of E-cadherin. ITGB3, vimentin and E-cadherin expression were determined by western blot analysis in cells transfected with miR-30a-5p mimics alone or in combination with either pcDNA 3.1+ (vector) or pcDNA 3.1+ containing a wild-type (ITGB3) or mutant ITGB3 (ITGB3 mut) expression cassette of the miR-30a-5p response element. β-actin was included as an internal control. 
Overexpression of miR-30a-5P or knockdown of ITGB3 inhibits hepatic metastasis of colon cancer cell in vivo SW480 cells (1×10
7
) were injected into the spleen of 30 mice to establish liver metastasis [38] and sacrificed 5 weeks after tumor cell injection for analysis. At 5 weeks after injection, the number of metastases in the livers of mice injected with SW480 cells transfected with miR-30a-5p was significantly lower than that of control and EV SW480 injected mice (Fig.  7A&B) . Similar to this,the number of metastases in the livers of mice injected with ITGB3-siRNA SW480 cells was significantly lower than that of control and EV SW480 injected mice (Fig. 7C&D) . These results indicated that miR-30a-5p suppresses metastasis of colon cancer cell and ITGB3 has the opposite effect.
Discussion
Although altered miRNA expression profiles have been observed in many types of malignancies [39, 40] , the molecular mechanisms by which miRNAs modulate cancer cells largely remain to be determined. Here, we investigated the potential role of miRNA-30a-5p in CRC progression. We demonstrated that miR-30a-5p was significantly downregulated in both human colon cancer tissues and cell lines, and found that downregulation of miR30a-5p contributed to cancer cell migration and invasion, which was associated with EMT. Furthermore, we showed that ectopic expression of miR-30a-5p in CRC cells inhibited cell migration and invasion, preventing EMT. We investigated the mechanisms underlying the function of miR-30a-5p in colon cancer and using target prediction software and a dualluciferase reporter assay, identified ITGB3 as a direct target of miR-30a-5p. We then showed the involvement of ITGB3 in the functional consequences of miR-30a-5p suppression. Our findings indicate the important role of miR-30a-5p in the fundamental processes of CRC metastasis (i.e. migration, invasion and EMT). Local invasion and distant metastasis are strongly correlated with poor prognosis in CRC patients and determining the mechanisms that govern metastasis is therefore crucial in developing treatments to improve patient survival rates. Both miR-30a-5p and its physiological target, ITGB3, may therefore be promising candidates for the development of novel therapeutic strategies for CRC.
The aberrant expression and distribution of integrin family members, including ITGB3, has previously been shown to promote tumor metastasis [41] [42] [43] . Integrins are transmembrane receptors that mediate cell-to-cell and cell-extracellular matrix attachments and facilitate signal transduction via intracellular signaling pathways such as PI3K and MAPK. Integrin heterodimers (comprising α and β subunits) regulate cell proliferation, survival and migration, predominantly via focal adhesion kinase and Src kinase family members [44, 45] , with small GTPases acting as intermediates in this process. In one study, an ITGB3 antagonist led to decreased colon cancer metastasis in mice [46] . The binding of integrins to ligands on the extracellular matrix has been shown to transmit both mechanical and chemical signals to induce cell cytoskeleton remodeling during adhesion and migration. In another study, reactive oxygen species were shown to markedly upregulate the expression of ITGB3, promoting a more aggressive phenotype in a colorectal cancer cell line with increased migratory and invasive capacities [47] . MiRNAs have been linked with the dysregulation of integrin signaling in a number of studies, correlating miRNA-regulated integrin signaling with tumor metastasis and apoptosis in CRC [28] , as well as breast, hepatocellular and salivary adenoid cystic carcinoma [7, 48, 49] . Our findings provide further evidence of the targeting of integrins by miRNAs.
In summary, we investigated the potential role of miR-30a-5p in tumor progression and its underlying mechanisms. Our findings indicate that downregulation of miR-30a-5p plays an important role in the development of CRC and that this miRNA is a promising therapeutic target. However, many aspects of miR-30a-5p function remain to be elucidated, including the complex effects on cellular behavior mediated by known targets (denticleless protein homolog, PIK3CD, insulin receptor substrate 2 and ITGB3) and potentially other yet to be determined target proteins.
